Beyond Benefits: The Unseen Risks of GLP-1 Receptor Agonists in Recent Trials

Beyond Benefits: The Unseen Risks of GLP-1 Receptor Agonists in Recent Trials

In recent years, GLP-1 receptor agonists (GLP-1RAs) have gained considerable attention in the medical community for their therapeutic potential. Currently approved for treating obesity and diabetes, these medications are also being investigated in numerous clinical trials for various new application...

Full description

Saved in:

Bibliographic Details
Main Author:	Mahmoud H. Elbatreek
Format:	Article
Language:	English
Published:	Zagazig University, Faculty of Pharmacy 2024-12-01
Series:	Zagazig Journal of Pharmaceutical Sciences
Online Access:	https://zjps.journals.ekb.eg/article_401829_d487fb83ba857f559eceb46cbb852a39.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)

The new era of aspiration risk: The dilemma of GLP-1 receptor agonists
by: Jack Madden, et al.
Published: (2024-03-01)

GLP-1 Receptor Agonists: Therapeutic Benefits in Renal Function, Cardiovascular Risk, and Physical Activity - A Systematic Review
by: Łukasz Karaban, et al.
Published: (2025-05-01)

Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk
by: Cheng-Hsien Hung, et al.
Published: (2024-12-01)

GLP-1 Receptor Agonists’ Impact on Fertility - A Review
by: Joanna Wojda, et al.
Published: (2025-02-01)

A Comprehensive Review on the Pharmacokinetics and Drug&minus;Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist
by: Min JS, et al.
Published: (2025-04-01)

Advances in GLP-1 receptor agonists for pain treatment and their future potential
by: Yongtao He, et al.
Published: (2025-02-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence
by: Maria S Varughese, et al.
Published: (2025-03-01)

The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation
by: Alberto Sola‐Leyva, et al.
Published: (2025-02-01)

GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
by: Ioannis Ilias, et al.
Published: (2025-01-01)

Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist
by: Gentinetta S, et al.
Published: (2024-12-01)

Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses
by: Hsuan-Wen Lai, et al.
Published: (2025-03-01)

Current and potential use of GLP-1R agonists: beyond type 2 diabetes
by: Graciela Zambrano-Galván, et al.
Published: (2024-10-01)

Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review
by: Bisma Fatima Hammad, et al.
Published: (2025-07-01)

Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists
by: Adrianna Tabeau, et al.
Published: (2025-03-01)

Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment
by: Łukasz Zdziebkowski, et al.
Published: (2025-07-01)

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
by: Cheney C, et al.
Published: (2025-05-01)

The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review
by: Marta Wolszczak, et al.
Published: (2025-06-01)

Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
by: Ahmad Moolla, et al.
Published: (2025-05-01)

61 Warfarin and GLP-1 Receptor Agonist Interaction Effects on Time in Therapeutic Range
by: Phillip Anjum, et al.
Published: (2025-05-01)

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Game Charger in the Field?
by: Georgia Doumani, et al.
Published: (2024-11-01)

Effects of GLP‐1 Receptor Agonists on Paediatric Population in a Real World Setting
by: A. G. Barajas, et al.
Published: (2025-05-01)

Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
by: Jung A Kim, et al.
Published: (2025-07-01)

GLP-1 receptor agonists and pulmonary hypertension in diabetes: A promising therapeutic strategy
by: Arif Albulushi, et al.
Published: (2025-07-01)

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
by: Dan Xu, et al.
Published: (2022-01-01)

Predictors of Responsiveness to GLP-1 Receptor Agonists in Insulin-Treated Patients with Type 2 Diabetes
by: Colleen Gavigan, et al.
Published: (2023-01-01)

Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
by: Renjiao Liu, et al.
Published: (2025-07-01)

Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
by: Marine Monney, et al.
Published: (2025-03-01)

Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies
by: Héctor Iván Saldívar-Cerón, et al.
Published: (2025-06-01)

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists
by: Haoran Jiang, et al.
Published: (2025-08-01)

Can GLP-1 receptor agonists slow the progression of Autosomal Dominant Polycystic Kidney Disease?
by: Hamad Ali, et al.
Published: (2025-06-01)

The weight of choices: Prioritizing lifestyle over GLP-1 receptor agonist therapy in managing MASLD
by: Jörn M. Schattenberg, et al.
Published: (2025-07-01)

GLP-1 receptor agonists in Parkinson’s disease: an updated comprehensive systematic review with meta-analysis
by: Mohamed Mohsen Helal, et al.
Published: (2025-08-01)

The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health
by: Mohamad Al Qassab, et al.
Published: (2025-04-01)

GLP-1 receptor agonists induce loss of lean mass: so does caloric restriction
by: Angelo Capodici, et al.

Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence
by: Srikanth Krishnan, et al.
Published: (2025-01-01)

The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions
by: Areesha Moiz, et al.
Published: (2025-08-01)

WCN25-3765 Title: Acalculous Cholecystitis, A rare complication of GLP 1 Receptor Agonist (GLP1 RA) after kidney transplant
by: Harshil Fichadiya, et al.
Published: (2025-02-01)

The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis
by: Ping-Tao Tseng, et al.
Published: (2025-04-01)